
Accenture (ACN) has received a high rating of 85% from Validea's 'Patient Investor' model, which emulates Warren Buffett's investment strategy. This assessment highlights ACN's strong fundamental characteristics, including predictable profitability, low debt, robust returns on equity and capital, and significant free cash flow, positioning the large-cap computer services firm as a compelling opportunity for long-term, value-oriented investors.
Accenture PLC (ACN) scores a high 85% on Validea's 'Patient Investor' model, which is calibrated to Warren Buffett's investment philosophy of acquiring companies with predictable, long-term profitability and low debt at reasonable valuations. This score, considered indicative of significant interest by the model, is underpinned by ACN's strong performance across several key fundamental criteria. The company passed tests for earnings predictability, debt service, return on equity, return on total capital, and free cash flow. Furthermore, the model positively assessed ACN's use of retained earnings and its initial and expected rates of return. The only area not receiving a full pass was its share repurchase program, which was rated as neutral. As a large-cap growth stock in the Computer Services industry, this comprehensive positive assessment highlights its alignment with quality-focused, long-term investment principles.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment